Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 7
2005 5
2006 4
2007 6
2008 3
2009 2
2010 1
2011 2
2012 4
2013 1
2015 2
2016 4
2017 3
2018 2
2019 2
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis.
Mehra C, Chung JH, He Y, Lara-Márquez M, Goyette MA, Boufaied N, Barrès V, Ouellet V, Guérard KP, Delliaux C, Saad F, Lapointe J, Côté JF, Labbé DP, Lamarche-Vane N. Mehra C, et al. Among authors: lapointe j. Commun Biol. 2021 Sep 7;4(1):1042. doi: 10.1038/s42003-021-02520-4. Commun Biol. 2021. PMID: 34493786 Free PMC article.
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.
Ebrahimizadeh W, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Patel PG, Jamaspishvili T, Hamel L, Aprikian AG, Lee AY, Berman DM, Bartlett JMS, Chevalier S, Lapointe J. Ebrahimizadeh W, et al. Among authors: lapointe j. Br J Cancer. 2023 Jun;128(12):2165-2174. doi: 10.1038/s41416-023-02236-8. Epub 2023 Apr 10. Br J Cancer. 2023. PMID: 37037938 Free PMC article.
Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.
Bramhecha YM, Guérard KP, Audet-Walsh É, Rouzbeh S, Kassem O, Pernet E, Scarlata E, Hamel L, Brimo F, Divangahi M, Aprikian AG, Chevalier S, Giguère V, Lapointe J. Bramhecha YM, et al. Among authors: lapointe j. Oncogene. 2022 May;41(20):2798-2810. doi: 10.1038/s41388-022-02276-z. Epub 2022 Apr 11. Oncogene. 2022. PMID: 35411033
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
Audet-Walsh É, Dufour CR, Yee T, Zouanat FZ, Yan M, Kalloghlian G, Vernier M, Caron M, Bourque G, Scarlata E, Hamel L, Brimo F, Aprikian AG, Lapointe J, Chevalier S, Giguère V. Audet-Walsh É, et al. Among authors: lapointe j. Genes Dev. 2017 Jun 15;31(12):1228-1242. doi: 10.1101/gad.299958.117. Epub 2017 Jul 19. Genes Dev. 2017. PMID: 28724614 Free PMC article.
50 results